日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Kinetically-derived maximal dose (KMD) confirms lack of human relevance for high-dose effects of octamethylcyclotetrasiloxane (D4)

动力学衍生最大剂量 (KMD) 证实八甲基环四硅氧烷 (D4) 高剂量效应与人类无关

Borgert, Christopher J; Burgoon, Lyle D; Fuentes, Claudio

Octamethylcyclotetrasiloxane (D4) lacks endocrine disruptive potential via estrogen pathways

八甲基环四硅氧烷(D4)不具有通过雌激素途径干扰内分泌的潜力

Borgert, Christopher J; Burgoon, Lyle D

Hypothesis-driven weight of evidence evaluation indicates ethylbenzene lacks endocrine disruption potential by EATS pathways

基于假设的证据权重评估表明,乙苯不具有通过EATS途径产生内分泌干扰的潜力。

Borgert, Christopher J

Kinetically-derived maximal dose (KMD) indicates lack of human carcinogenicity of ethylbenzene

动力学衍生最大剂量 (KMD) 表明乙苯对人类无致癌性。

Burgoon, Lyle D; Borgert, Christopher J; Fuentes, Claudio; Klaunig, James E

The physiological and biochemical basis of potency thresholds modeled using human estrogen receptor alpha: implications for identifying endocrine disruptors

利用人雌激素受体α模型构建效力阈值的生理和生化基础:对识别内分泌干扰物的意义

Borgert, Christopher J; Burgoon, Lyle D; Matthews, John C

US regulations to curb alleged cancer causes are ineffectual and compromised by scientific, constitutional and ethical violations

美国旨在遏制所谓致癌因素的法规无效,并且因违反科学、宪法和伦理准则而受到损害。

Gori, Gio B; Aschner, Michael; Borgert, Christopher J; Cohen, Samuel M; Dietrich, Daniel R; Galli, Corrado L; Greim, Helmut; Heslop-Harrison, John S; Kacew, Sam; Kaminski, Norbert E; Klaunig, James E; Marquardt, Hans W J; Pelkonen, Olavi; Roberts, Ruth; Savolainen, Kai M; Tsatsakis, Aristidis; Yamazaki, Hiroshi

Issue analysis: key characteristics approach for identifying endocrine disruptors

问题分析:识别内分泌干扰物的关键特征方法

Borgert, Christopher J

A novel approach to calculating the kinetically derived maximum dose

一种计算动力学衍生最大剂量的新方法

Burgoon, Lyle D; Fuentes, Claudio; Borgert, Christopher J

Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity: how to evaluate the risk of the S-EDCs?

与具有更高或相当的内分泌活性的天然化合物相比,人类接触合成内分泌干扰物 (S-EDC) 的情况通常微不足道:如何评估 S-EDC 的风险?

Autrup, Herman; Barile, Frank A; Berry, Sir Colin; Blaauboer, Bas J; Boobis, Alan; Bolt, Herrmann; Borgert, Christopher J; Dekant, Wolfgang; Dietrich, Daniel; Domingo, Jose L; Gori, Gio Batta; Greim, Helmut; Hengstler, Jan; Kacew, Sam; Marquardt, Hans; Pelkonen, Olavi; Savolainen, Kai; Heslop-Harrison, Pat; Vermeulen, Nico P

Human-relevant potency threshold (HRPT) for ERα agonism

ERα激动剂的人类相关效力阈值(HRPT)

Borgert, Christopher J; Matthews, John C; Baker, Stephen P